SOPHiA GENETICS (SOPH) Enterprise Value (2020 - 2025)

SOPHiA GENETICS has disclosed Enterprise Value across 6 years of filings, most recently posting -$70.3 million for Q4 2025.

• Enterprise Value for Q4 2025 came in at -$70.3 million, up 42.97% year-over-year; the trailing twelve-month figure through Dec 2025 was -$70.3 million (up 42.97% YoY), and the FY2025 annual result was -$70.3 million, up 42.97% from the prior year.
• Enterprise Value came in at -$70.3 million for Q4 2025 at SOPHiA GENETICS, up from -$81.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$64.1 million in Q2 2021 to a low of -$280.6 million in Q3 2021.
• The 5-year median for Enterprise Value is -$123.3 million (2023), against an average of -$147.1 million.
• Across the five-year window, Enterprise Value plunged 1452.69% in 2021 and soared 42.97% in 2025, its largest moves.
• SOPHiA GENETICS's Enterprise Value stood at -$265.3 million in 2021, then surged by 32.68% to -$178.6 million in 2022, then surged by 31.0% to -$123.3 million in 2023, then changed by 0.0% to -$123.3 million in 2024, then soared by 42.97% to -$70.3 million in 2025.
• The last three Enterprise Value figures came in at -$70.3 million (Q4 2025), -$81.6 million (Q3 2025), and -$94.8 million (Q2 2025), per Business Quant data.